New report reveals 3 top stocks experts predict are about to skyrocket. Download it free. Check out 3 software stocks with huge profit potential. Download new report free.
- 2024's Gold Rush is Here
Gold Prices Could Reach New Highs
See This Year's Top Gold Plays Free
- Top Clean Energy Stocks
How to profit from surging demand.
Free report reveals 5 hot stocks.
- Top Hydrogen Stock Plays
5 Hydrogen stocks to buy right now
New report names 5 wealth-builders
- 3 Hottest Software Stocks
Top plays from a surging industry.
Free report names must-buy stocks.
- Top EV Stocks to Buy Now
5 EV Picks Better than Tesla
5 Stocks with Big Profit Potential
- The Top IPO Stock Plays
Could IPOs be the Key to Success?
Investing in IPOs is on the Rise
- 2024's Gold Rush is Here
Search results
4 days ago · What is Heron Therapeutics' forecast for 2024? According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for Heron Therapeutics is $6.00, with a high forecast of $7.00 and a low forecast of $5.00. Should I buy or sell Heron Therapeutics stock right now?
- (858) 251-4400
- 4242 CAMPUS POINT COURT SUITE 200, SAN DIEGO CA, 92121
- ir@herontx.com
Oct 25, 2024 · Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates. Net Product Sales of $34.7 million, which increased from $29.6 million for the same period in 2023. Net Loss Per Share $ (0.02), which decreased from $ (0.27) for the same period in 2023. 6 months ago - PRNewsWire.
- 274.52M
- 136.36M
- 48.13M
- 151.67M
4 days ago · Price Target. $6.00. Consensus Rating. Buy. Company Overview. Heron Therapeutics, Inc., a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology ...
- (858) 251-4400
- 4242 CAMPUS POINT COURT SUITE 200, SAN DIEGO CA, 92121
- ir@herontx.com
3 days ago · Stock Price Forecast. The 3 analysts with 12-month price forecasts for Heron Therapeutics stock have an average target of 6.00, with a low estimate of 5.00 and a high estimate of 7.00. The average target predicts an increase of 246.82% from the current stock price of 1.73.
4 days ago · A high-level overview of Heron Therapeutics, Inc. (HRTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Heron Therapeutics, Inc. announced that it has received $76.499144 million in funding from Deep Track Capital, LP, Great Point Partners, LLC, Broadfin Holdings LLC. Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind.
People also ask
What was Heron Therapeutics' stock price in 2024?
Is Heron Therapeutics a good stock to buy?
What is the 12-month price forecast for heron Therapeutics (hrtx)?
What is hrtx Heron Therapeutics (hrtx) stock price?
What does Heron Therapeutics do?
Should you buy Heron Therapeutics (hrtx) in 2023?
5 days ago · See the latest Heron Therapeutics Inc stock price (HRTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
